Presti Joseph C
Stanford Cancer Center, Stanford, CA 94305-5826, USA.
Nat Clin Pract Urol. 2007 Sep;4(9):505-11. doi: 10.1038/ncpuro0887.
Early detection is critical to good management of prostate cancer patients. Markers for detection, such as prostate specific antigen (PSA), and prostate biopsy are paramount for establishing an efficient diagnosis. Patients having an initial biopsy should undergo an extended biopsy scheme incorporating at least 10-12 cores, while in those undergoing a repeat biopsy particular attention should be addressed to the anterior apex. Saturation biopsies should be considered for patients with several prior negative biopsies. The chance of finding cancer on repeat biopsies has diminished in patients harboring high-grade prostatic intraepithelial neoplasia but not in those with atypical small acinar proliferation. This article reviews the history of prostate biopsy strategies with particular attention paid towards the development of extended biopsy schemes. Furthermore, a strategy is recommended for initial and repeat biopsy patients.
早期检测对于前列腺癌患者的良好管理至关重要。检测标志物,如前列腺特异性抗原(PSA)和前列腺活检,对于建立有效的诊断至关重要。初次活检的患者应采用至少包含10 - 12个组织芯的扩展活检方案,而对于接受重复活检的患者,应特别关注前列腺尖前部。对于之前多次活检阴性的患者,应考虑进行饱和活检。在患有高级别前列腺上皮内瘤变的患者中,重复活检发现癌症的几率有所降低,但在非典型小腺泡增生患者中并非如此。本文回顾了前列腺活检策略的历史,特别关注扩展活检方案的发展。此外,还为初次活检和重复活检患者推荐了一种策略。